RxSight, Inc.: cash_and_equivalents
| Value | {"amount": 11012000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2023-03-31) |
| Status | current |
| Entity | RxSight, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T11:09:18.754153+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/f9be38be-1481-42c3-bcf5-8de48ce8cac4
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-23-019703Retrieved: 2026-08-19T11:09:18.754153+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001111485/cash-and-equivalents/2023-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/f9be38be-1481-42c3-bcf5-8de48ce8cac4
History
- no predecessors — first report